Jefferies Group’s Kura Oncology KURA Stock Holding History

Jefferies Group’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16,414	Closed	-$226K	–	2389
2019 Q4	$226K	Buy	+16,414	New	+$243K	﹤0.01%	2198

Other funds holding KURA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Group's KURA Position: Q1 2020 in Review

Jefferies Group sold out of Kura Oncology (KURA) in Q1 2020, closing a stake of 16,414 shares — an estimated $226K sold.

Jefferies Group first reported a position in KURA in Q4 2019 and held it in 1 quarter. The position peaked at $226K in Q4 2019. 119 funds tracked by Wall St. Rank hold KURA as of Q1 2020.

Jefferies Group reported no remaining Kura Oncology position as of Q1 2020 after selling out during the quarter.
Jefferies Group sold 16,414 Kura Oncology shares in Q1 2020, an estimated $226K.
Jefferies Group first reported a position in Kura Oncology in Q4 2019 and held it in 1 quarter.
Jefferies Group's Kura Oncology position peaked at $226K in Q4 2019.
119 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.